The NONA-LISA Trial
Recruiting
N/A
Interventional Study
Respiratory Distress Syndrome in Premature Infant
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 24 Weeks – 30 Weeks
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 324 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The NONA-LISA trial will be an investigator-initiated, multicentre, pragmatic, parallel-group, blinded RCT conducted at four university hospitals across Denmark. A total of 324 inborn premature infants will be included within 36 months at four neonatal intensive care units (NICUs) across Denmark (approximately 2 infants per month per unit).
The aim is to compare LISA using a non-pharmacological a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Infants born at one of the trial sites with a gestational age of 24+0 to 29+6 weeks and meeting the criteria for first-choice surfactant treatment by LISA as described by Sweet et al.: worsening babies with RDS and FiO2 \> 0.30 on CPAP pressure ≥6 cm H2O.
Exclusion Criteria:
…
Contacts